secwatch.observer — SEC 8-K summary
======================================

Issuer:     CytoDyn Inc. (CYDY)
CIK:        0001175680
Form:       8-K
Filed at:   2022-04-25T23:59:59+00:00
Accession:  0001193125-22-117768
Event type: leadership
Sentiment:  neutral
Materiality: 0.50
Item codes: 5.02
LLM model:  deepseek-v4-flash:cloud@v2

CytoDyn reorganizes management: Ray remains CTO, Recknor no longer executive officer
--------------------------------------------------------------------------------

- Nitya G. Ray, Ph.D., no longer COO; continues as Chief Technology Officer.
- Christopher P. Recknor, M.D., named Senior Director of R&D, ceases to be executive officer.
- Board approved reorganization on April 19, 2022; effective immediately.

Source:
  EDGAR index:    https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/0001193125-22-117768-index.htm
  Primary doc:    https://www.sec.gov/Archives/edgar/data/1175680/000119312522117768/d341269d8k.htm
  HTML page:      https://secwatch.observer/filing/0001193125-22-117768

License: Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer